Skip to main content

Advertisement

Log in

Novel Therapeutics for Addiction: Behavioral Economic and Neuroeconomic Approaches

  • Substance Use Disorders (FG Moeller, Section Editor)
  • Published:
Current Treatment Options in Psychiatry Aims and scope Submit manuscript

Opinion statement

Behavioral economic and neuroeconomic understandings of addiction offer both established and empirically supported treatments as well as a foundation from which promising new treatment options are emerging. Addiction must be understood and treated as a state of pathological overvaluation of the reinforcement of drug use fueled by an imbalance of the competing neurobehavioral decision systems that govern decision making (CNDS theory). The CNDS theory presents two systems, the executive and impulsive, which are dysregulated in reinforcer pathology by greater relative control of the impulsive, hedonic system, and lesser relative control of the executive, regulatory system. This leads to a reinforcer pathology where drug use is maladaptively overvalued in comparison to other reinforcers, leading to a chronic and often relapsing state of addiction. Some treatments which directly alter economic variables associated with drug use have already been empirically supported, including contingency management (which increases the short-term price of drug use) and drug agonist therapies (which decrease the short-term value of drug use compared to other reinforcers). New, promising treatments which bring the fundamental CNDS dysregulation of addiction into balance include episodic future thinking, which increases the temporal window over which the opportunity costs of drug use are integrated by engaging executive control, and TMS therapies which directly increase activity, and therefore relative control, in the executive system. The maturing fields of behavioral economics and neuroeconomics provide conceptual understanding of the competing neurobehavioral decision systems theory (CNDS) and reinforcer pathology (i.e., high valuation of and excessive preference for drug reinforcers), allowing us to coherently categorize treatments into a theoretically comprehensive framework of addiction. In this chapter, we identify and clarify how existing and novel interventions can ameliorate reinforcer pathology in light of the CNDS and be leveraged to treat addiction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Notes

  1. We note that dominant control by the executive system may produce pathologies other than addiction, such as those characterized by excessive concern over future events (e.g., anorexia nervosa and obsessive-compulsive disorder). However, our focus in this chapter is on dominant control by the impulsive system and the resulting risk for addiction.

  2. For further discussion of contingency management in the other subtype of reinforcer pathology and the executive decision system of the CNDS, see [13].

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Bickel WK, Degrandpre RJ, Higgins ST, Hughes JR. Behavioral economics of drug self-administration. I. Functional equivalence of response requirement and drug dose. Life Sci. 1990;47:1501–10.

    Article  CAS  PubMed  Google Scholar 

  2. Glimcher P. Decisions, uncertainty, and the brain: the science of neuroeconomics. Cambridge, Mass: MIT Press; 2003. 395 p.

    Google Scholar 

  3. Bickel WK, Miller ML. Yi R, Kowal BP, Lindquist DM, Pitcock Ja. Behavioral and neuroeconomics of drug addiction: Competing neural systems and temporal discounting processes. Drug Alcohol Depend. 2007;90:85–91.

    Article  Google Scholar 

  4. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci. 2005;8:1458–63.

    Article  CAS  PubMed  Google Scholar 

  5. Bickel WK, Mueller ET, Jarmolowicz DP. What is Addiction? In: McCrady B, Epstein E, editors. Addictions: a comprehensive guidebook. 2nd ed. New York: Oxford University Press; 2013.

    Google Scholar 

  6. Bjork JM, Smith AR, Hommer DW. Striatal sensitivity to reward deliveries and omissions in substance dependent patients. Neuroimage. 2008;42(4):1609–21.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bickel WK, Jarmolowicz DP, Mueller ET, Gatchalian KM, McClure SM. Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction. Psychopharmacology. 2012;221:361–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Quisenberry AJ, Koffarnus MN, Hatz LE, Epstein LH, Bickel WK. The experimental tobacco marketplace i: substitutability as a function of the price of conventional cigarettes. Nicotine Tob Res. 2015.

  9. Mackillop J, Few LR, Murphy JG, Wier LM, Acker J, Murphy C, et al. High-resolution behavioral economic analysis of cigarette demand to inform tax policy. Addiction. 2012;107(12):2191–200.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bickel WK, Moody L, Quisenberry AJ, Ramey CT, Sheffer CE. The competing neurobehavioral decision systems model of SES-related health and behavioral disparities. Preventative Medicine. 2013;18:1199–216.

    Google Scholar 

  11. Bickel W, Jarmolowicz D, MacKillop J. The behavioral economics of reinforcement pathologies: novel approaches to addictive disorders. APA Addiction Syndrome Handbook. 22012. p. 333–63.

  12. Bickel WK, Johnson MW, Koffarnus MN, Mackillop J, Murphy JG. The behavioral economics of substance use disorders: reinforcement pathologies and their repair. Annu Rev Clin Psychol. 2014;10:641–77. This article links the overvaluation of drug reinforcement with the preference for the immediate choice to describe reinforcer pathology. It contains descriptions of the etiology of reinforcer pathology and approaches and procedures that can improve them.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Bickel WK, Snider SE, Quisenberry AJ, Stein JS, Hanlon CA. Competing neurobehavioral decision systems theory of cocaine addiction: From mechanisms to therapeutic opportunities. Progress in Brain Research. 2015:1–25. This chapter provides an overview of the CNDS theory of addiction through the chronically relapsing condition of cocaine dependence. It offers a unified understanding of impulsivity, developmental time course, comorbidities, and neuro-phenotype of cocaine dependence.

  14. Sofis MJ, Jarmolowicz DP, Martin LE. Competing neurobehavioral decision systems and the neuroeconomics of craving in opioid addiction. Neuroscience & Neuroeconomicss. 2014;3:87–99.

    Google Scholar 

  15. Kahneman D. Thinking, fast and slow. New York: Farrar, Straus, and Giroux; 2011. 512 p.

    Google Scholar 

  16. Metcalfe J, Mischel W. A hot/cool system analysis of delay of gratification: dynamics of willpower. Psychol Rev. 1999;106(1):3–19.

    Article  CAS  PubMed  Google Scholar 

  17. Pinto A, Steinglass JE, Greene AL, Weber EU, Simpson HB. Capacity to delay reward differentiates obsessive-compulsive disorder and obsessive-compulsive personality disorder. Biol Psychiatry. 2014;75(8):653–9.

    Article  PubMed  Google Scholar 

  18. Steinglass JE, Figner B, Berkowitz S, Simpson HB, Weber EU, Walsh BT. Increased capacity to delay reward in anorexia nervosa. J Int Neuropsychol Soc. 2012;18(4):773–80.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Bickel WK, Jarmolowicz DP, Mueller ET, Gatchalian KM. The behavioral economics and neuroeconomics of reinforcer pathologies: implications for etiology and treatment of addiction. Curr Psychiatry Rep. 2011;13(5):406–15.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hursh SR, Silberberg A. Economic demand and essential value. Psychol Rev. 2008;115:186–98.

    Article  PubMed  Google Scholar 

  21. Hursh SR, Roma PG. Behavioral economics and empirical public policy. J Exp Anal Behav. 2013;99:98–124. This chapter summarizes insights from behavioral economics relevant to basic research, preclinical behavioral pharmacology, and clinical drug abuse. It describes demand curve analysis to allow for cross-commodity comparisons of reinforcer valuation and defines common interactions between commodities.

    Article  PubMed  Google Scholar 

  22. Few LR, Acker J, Murphy C, Mackillop J. Temporal stability of a cigarette purchase task. Nicotine Tob Res. 2012;14:761–5.

    Article  PubMed  Google Scholar 

  23. Murphy JG, MacKillop J, Skidmore JR, Pederson AA. Reliability and validity of a demand curve measure of alcohol reinforcement. Exp Clin Psychopharmacol. 2009;17:396–404.

    Article  PubMed  Google Scholar 

  24. Murphy JG, Mackillop J, Tidey JW, Brazil LA, Colby SM. Validity of a demand curve measure of nicotine reinforcement with adolescent smokers. Drug Alcohol Depend. 2011;113(2–3):207–14.

    Article  CAS  PubMed  Google Scholar 

  25. Yurasek AM, Murphy JG, Clawson AH, Dennhardt AA, Mackillop J. Smokers report greater demand for alcohol on a behavioral economic purchase task. J Stud Alcohol Drugs. 2013;74:626–34.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Mackillop J, Murphy JG. A behavioral economic measure of demand for alcohol predicts brief intervention outcomes. Drug Alcohol Depend. 2007;89(2–3):227–33.

    Article  PubMed  Google Scholar 

  27. Madden GJ, Petry NM, Badger GJ, Bickel WK. Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Exp Clin Psychopharmacol. 1997;5:256–62.

    Article  CAS  PubMed  Google Scholar 

  28. Audrain-Mcgovern J, Rodriguez D, Epstein LH, Cuevas J, Rodgers K, Wileyto EP. Does delay discounting play an etiological role in smoking or is it a consequence of smoking? Drug Alcohol Depend. 2009;103:99–106.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Bickel WK, Koffarnus MN, Moody L, Wilson AG. The behavioral- and neuro-economic process of temporal discounting: a candidate behavioral marker of addiction. Neuropharmacology. 2014;76:518–27.

    Article  CAS  PubMed  Google Scholar 

  30. Mackillop J, Amlung MT, Few LR, Ray L, Sweet LH, Munafò MR. Delayed reward discounting and addictive behavior: a meta-analysis. Psychopharmacology. 2011;216:305–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Green L, Fry AF, Myerson D o d r. A Life-Span Comparison. Psychol Sci. 1994;5:33–6.

    Article  Google Scholar 

  32. Green L, Myerson J, Lichtman D, Rosen S, Fry A. Temporal discounting in choice between delayed rewards: the role of age and income. Psychol Aging. 1996;11:79–84.

    Article  CAS  PubMed  Google Scholar 

  33. Pinkston JW, Lamb RJ. Delay discounting in C57BL/6J and DBA/2J mice: adolescent-limited and life-persistent patterns of impulsivity. Behav Neurosci. 2011;125(2):194–201.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Tobin H, Logue AW. Self-control across species (Columba livia, Homo sapiens, and Rattus norvgicus. J Cogn Psychother. 1994;108(2):126–33.

    CAS  Google Scholar 

  35. Hursh SR. Behavioral economics of drug self-administration and drug abuse policy. J Exp Anal Behav. 1991;56(2):377–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Hursh SR. Behavioral economics and the analysis of consumption and choice. In: Mcsweeney FK, Murphy ES, editors. The Wiley Blackwell handbook of operant and classical conditioning. Hoboken: Wiley; 2014. p. 275–305. This chapter describes complements, substitutes, and independents as well as providing a novel equation to quantify cross-price elasticity. This offers insights not just into the elasticity of a commodity’s own price but direct report on the effect of a second commodity’s price on consumption of the first commodity.

    Chapter  Google Scholar 

  37. Degrandpre RJ, Bickel WK, Hughes JR, Layng MP, Badger GJ. Unit price as a useful metric in analyzing effects of reinforcer magnitude. J Exp Anal Behav. 1993;60(3):641–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Greenwald MK, Hursh SR. Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of unit price and pre-session drug supply. Drug Alcohol Depend. 2006;85(1):35–48.

    Article  PubMed  Google Scholar 

  39. Bickel WK et al. Modeling the effects of combined behavioral and pharmacological treatment on cigarette smoking: behavioral-economics analyses. Exp Clin Psychopharmacol. 1997;5(4):334–43.

    Article  CAS  PubMed  Google Scholar 

  40. Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006;101(11):1546–60.

    Article  PubMed  Google Scholar 

  41. Higgins ST, Petry NM. Contingency management: incentives for sobriety. Alcohol Res Health. 1999;23(2):122–7.

    CAS  PubMed  Google Scholar 

  42. Murphy JG, Correia CJ, Barnett NP. Behavioral economic approaches to reduce college student drinking. Addict Behav. 2007;32(11):2573–85.

    Article  PubMed  Google Scholar 

  43. Walters ST, Neighbors C. Feedback interventions for college alcohol misuse: what, why and for whom? Addict Behav. 2005;30(6):1168–82.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Dennhardt AA, Murphy JG. Prevention and treatment of college student drug use: a review of the literature. Addict Behav. 2013;38(10):2607–18.

    Article  PubMed  Google Scholar 

  45. Dennhardt AA, Yurasek AM, Murphy JG. Change in delay discounting and substance reward value following a brief alcohol and drug use intervention. J Exp Anal Behav. 2015;103:125–40.

    Article  PubMed  Google Scholar 

  46. Eichhammer P, Johann M, Kharraz A, Binder H, Pittrow D, Wodarz N, et al. High frequency repetitive transcranial magnetic stimulation decreases cigarette smoking. J Clin Psychiatry. 2003;64(8):951–3.

    Article  PubMed  Google Scholar 

  47. Amiaz R, Levy D, Vainiger D, Grunhaus L, Zangen A. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction (Abingdon, England). 2009;104:653–60.

    Article  Google Scholar 

  48. Terraneo A, Leggio L, Ermani M, Bonci A. Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: a pilot study. Eur Neuropsychopharmacol. 2015;1–8.

  49. Bickel WK, Degrandpre RJ, Higgins ST. The behavioral economics of concurrent drug reinforcers: a review and reanalysis of drug self-administration research. Psychopharmacology. 1995;118(3):250–9.

    Article  CAS  PubMed  Google Scholar 

  50. Johnson MW, Bickel WK, Kirshenbaum AP. Substitutes for tobacco smoking: a behavioral economic analysis of nicotine gum, denicotinized cigarettes, and nicotine-containing cigarettes. Drug Alcohol Depend. 2004;74:253–64.

    Article  PubMed  Google Scholar 

  51. Johnson MW, Bickel WK. The behavioral economics of cigarette smoking: the concurrent presence of a substitute and an independent reinforcer. Behav Pharmacol. 2003;14(2):137–44.

    Article  CAS  PubMed  Google Scholar 

  52. Budney AJ, Bickel WK, Hughes JR. A behavioral approach to achieving initial cocaine abstinence. Am J Psychiatr. 1991;148:1218–24.

    Article  PubMed  Google Scholar 

  53. Secades-Villa R, Garcia-Rodriguez O, Higgins ST, Fernandez-Hermida JR, Carballo JL. Community reinforcement approach plus vouchers for cocaine dependence in a community setting in Spain: six-month outcomes. J Subst Abuse Treat. 2008;34(2):202–7.

    Article  PubMed  Google Scholar 

  54. Higgins ST, Sigmon SC, Wong CJ, Badger GJ, Donham R, et al. Community reinforcement therapy for cocaine-dependent outpatients. Arch Gen Psychiatry. 2003;60(10):1043–52.

    Article  PubMed  Google Scholar 

  55. Hunt GM, Azrin NH. A community-reinforcement approach to alcoholism. Behav Res Ther. 1973;11:91–104.

    Article  CAS  PubMed  Google Scholar 

  56. Sofuoglu M. Cognitive enhancement as a pharmacotherapy target for stimulant addiction. Addiction. 2010;105(1):38–48.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Mattick R, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database System Reviews. 2009;1(3).

  58. Bickel WK, Stitzer M, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE. A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. Clin Pharmacol Ther. 1988;43(1):72–8.

    Article  CAS  PubMed  Google Scholar 

  59. Campbell A, Nunes E, Matthews A, Stitzer M, Miele G, Polsky D, et al. Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatr. 2014;171:683–90.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Bickel WK, Quisenberry AJ, Moody L, Wilson AG. Therapeutic opportunities for self-control repair in addiction and related disorders: change and the limits of change in trans-disease processes. Clin Psychol Sci. 2014;3:140–53. This review describes the CNDS as a dual model of self control failure and specifically highlights altered delay discounting as a hallmark of multiple diseases in which the balance between these two systems is altered.

    Article  PubMed Central  Google Scholar 

  61. Wesley MJ, Bickel WK. Remember the future II: meta-analyses and functional overlap of working memory and delay discounting. Biol Psychiatry. 2014;75(6):435–48.

    Article  PubMed  Google Scholar 

  62. Hinson JM, Jameson TL, Whitney P. Impulsive decision making and working memory. J Exp Psychol Learn Mem Cogn. 2003;29(2):298–306.

    Article  PubMed  Google Scholar 

  63. Griffiths A, Hill R, Morgan C, Rendell PG, Karimi K, Wanagaratne S, et al. Prospective memory and future event simulation in individuals with alcohol dependence. Addiction. 2012;107(10):1809–16.

    Article  PubMed  Google Scholar 

  64. Hester R, Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci. 2004;24(49):11017–22.

    Article  CAS  PubMed  Google Scholar 

  65. Hofmann W, Schmeichel BJ, Baddeley AD. Executive functions and self-regulation. Trends Cogn Sci. 2012;16(3):174–80.

    Article  PubMed  Google Scholar 

  66. Mendrek A, Monterosso J, Simon SL, Jarvik M, Brody A, Olmstead R, et al. Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. Addict Behav. 2006;31(5):833–44.

    Article  PubMed  Google Scholar 

  67. Xu J, Mendrek A, Cohen MS, Monterosso J, Rodriguez P, Simon SL, et al. Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. Biol Psychiatry. 2005;58(2):143–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Jacobsen LK, Mencl WE, Constable RT, Westerveld M, Pugh KR. Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers. Psychopharmacology (Berl). 2007;193(4):557–66.

    Article  CAS  Google Scholar 

  69. Patterson F, Jepson C, Loughead J, Perkins K, Strasser AA, Siegel S, et al. Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend. 2010;106(1):61–4.

    Article  PubMed  Google Scholar 

  70. Bechara A, Martin EM. Impaired decision making related to working memory deficits in individuals with substance addictions. Neuropsychology. 2004;18(1):152–62.

    Article  PubMed  Google Scholar 

  71. Bickel WK, Yi R, Landes RD, Hill PF, Baxter C. Remember the future: working memory training decreases delay discounting among stimulant addicts. Biol Psychiatry. 2011;69(3):260–5.

    Article  PubMed  Google Scholar 

  72. Houben K, Wiers RW, Jansen A. Getting a grip on drinking behavior: training working memory to reduce alcohol abuse. Psychol Sci. 2011;22(7):968–75.

    Article  PubMed  Google Scholar 

  73. Bickel WK, Moody L, Quisenberry AJ. Computerized working-memory training as a candidate adjunctive treatment for addiction. Alcohol Res. 2014;36(1):123–6.

    PubMed  PubMed Central  Google Scholar 

  74. Rass O, Schacht RL, Buckheit K, Johnson MW, Strain EC, Mintzer MZ. A randomized controlled trial of the effects of working memory training in methadone maintenance patients. Drug Alcohol Depend. 2015;156:38–46.

    Article  PubMed  Google Scholar 

  75. Olesen PJ, Westerberg H, Klingberg T. Increased prefrontal and parietal activity after training of working memory. Nat Neurosci. 2004;7(1):75–9.

    Article  CAS  PubMed  Google Scholar 

  76. Klingberg T. Training and plasticity of working memory. Trends Cogn Sci. 2010;14(7):317–24.

    Article  PubMed  Google Scholar 

  77. Lin H, Epstein LH. Living in the moment: effects of time perspective and emotional valence of episodic thinking on delay discounting. Behav Neurosci. 2014;128(1):12–9.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Peters J, Buchel C. Episodic future thinking reduces reward delay discounting through an enhancement of prefrontal-mediotemporal interactions. Neuron. 2010;66(1):138–48.

    Article  CAS  PubMed  Google Scholar 

  79. Dassen FC, Jansen A, Nederkoorn C, Houben K. Focus on the future: episodic future thinking reduces discount rate and snacking. Appetite. 2016;96:327–32.

    Article  PubMed  Google Scholar 

  80. Daniel TO, Stanton CM, Epstein LH. The future is now: reducing impulsivity and energy intake using episodic future thinking. Psychol Sci. 2013;24(11):2339–42.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Schacter DL, Benoit RG, De Brigard F, Szpunar KK. Episodic future thinking and episodic counterfactual thinking: intersections between memory and decisions. Neurobiol Learn Mem. 2015;117:14–21.

    Article  PubMed  Google Scholar 

  82. O’Neill J, Daniel TO, Epstein LH. Episodic future thinking reduces eating in a food court. Eat Behav. 2016;20:9–13.

    Article  PubMed  Google Scholar 

  83. Snider SE, LaConte SM, Bickel WK. Episodic future thinking: expansion of the temporal window in alcohol dependents. Alcoholism: clinical and experimental research. 2016;1–9. doi: 10.1111/acer.13112.

  84. Bertossi E, Aleo F, Braghittoni D, Ciaramelli E. Stuck in the here and now: construction of fictitious and future experiences following ventromedial prefrontal damage. Neuropsychologia. 2015;81:107–16.

    Article  PubMed  Google Scholar 

  85. Okuda J, Fujii T, Ohtake H, Tsukiura T, Tanji K, Suzuki K, et al. Thinking of the future and past: the roles of the frontal pole and the medial temporal lobes. NeuroImage. 2003;19(4):1369–80.

    Article  PubMed  Google Scholar 

  86. Benoit RG, Gilbert SJ, Burgess PW. A neural mechanism mediating the impact of episodic prospection on farsighted decisions. J Neurosci. 2011;31(18):6771–9.

    Article  CAS  PubMed  Google Scholar 

  87. Cho SS, Koshimori Y, Aminian K, Obeso I, Rusjan P, Lang AE, et al. Investing in the future: stimulation of the medial prefrontal cortex reduces discounting of delayed rewards. Neuropsychopharmacology. 2014;40:1–8.

    Google Scholar 

  88. Cho SS, Ko JH, Pellecchia G, Van Eimeren T, Cilia R, Strafella AP. Continuous theta burst stimulation of right dorsolateral prefrontal cortex induces changes in impulsivity level. Brain stimulation. 2010;3:170–6.

    Article  PubMed  Google Scholar 

  89. Sheffer CE, Mennemeier M, Landes RD, Bickel WK, Brackman S, Dornhoffer J, et al. Neuromodulation of delay discounting, the reflection effect, and cigarette consumption. J Subst Abus Treat. 2013;45:206–14.

    Article  Google Scholar 

  90. Figner B, Knoch D, Johnson EJ, Krosch AR, Lisanby SH, Fehr E, et al. Lateral prefrontal cortex and self-control in intertemporal choice. Nat Neurosci. 2010;13(5):538–9.

    Article  CAS  PubMed  Google Scholar 

  91. Koffarnus MN, Jarmolowicz DP, Mueller ET, Bickel WK. Changing delay discounting in the light of the competing neurobehavioral decision systems theory: a review. J Exp Anal Behav. 2013;99:32–57.

    Article  PubMed  Google Scholar 

  92. Bickel WK, Quisenberry AJ, Snider SE. Does impulsivity change rate dependently following stimulant administration? Psychopharmacology: A translational selective review and re-analysis; 2015.

    Google Scholar 

  93. Gray J, Mackillop J. Impulsive delayed reward discounting as a genetically- influenced target for drug abuse prevention: a critical evaluation. Front Psychol. 2015;6:1–13.

    Google Scholar 

  94. Schmaal L, Goudriaan AE, Joos L, Dom G, Pattij T, van den Brink W, et al. Neural substrates of impulsive decision making modulated by modafinil in alcohol-dependent patients. Psychol Med. 2014;44(13):2787–98.

    Article  CAS  PubMed  Google Scholar 

  95. Quisenberry AJ, Snider SE, Bickel WK. The return of rate dependence: a commentary. Behavioral Analysis: Research and Practice. 2016 (in press).

  96. Snider SE, Quisenberry AJ, Bickel WK. Order in the absence of an effect: rate dependent relationships revealed. Behavioural Processes. 2016;127:18–24.

  97. Wenger GR, Dews PB. The effects of phencyclidine, ketamine, d-amphetamine and pentobarbital on schedule-controlled behavior in the mouse. J Pharmacol Exp Ther. 1976;616–24.

  98. Herremans SC, De Raedt R, Van Schuerbeek P, Marinazzo D, Matthys F, De Mey J, et al. Accelerated HF-rTMS protocol has a rate-dependent effect on dACC activation in alcohol-dependent patients: an open-label feasibility study. Alcohol Clin Exp Res. 2016;40:196–205.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The following grants contributed to the support of the authors during the development of this work: NIH grants R01AA021529, R01DA034755, U19CA157345, UH2DK109543, and F31AA024368-01.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Warren K. Bickel Ph.D.

Ethics declarations

Conflict of interest

Warren K. Bickel declares that he has no conflict of interest.

Alexandra M. Mellis declares that she has no conflict of interest.

Sarah E. Snider declares that she has no conflict of interest.

Lara Moody declares that she has no conflict of interest.

Jeffrey S. Stein declares that he has no conflict of interest.

Amanda J. Quisenberry declares that she has no conflict of interest.

Human and animal rights and informed consent

This article contains citations to studies with human subjects performed by authors Warren K. Bickel, Sarah E. Snider, Jeffery S. Stein, and Amanda J. Quisenberry. All studies performed by authors with human subjects were approved by the institutional review boards where the research was completed. This article does not contain any studies with animal subjects performed by its authors.

Additional information

This article is part of the Topical Collection on Substance Use Disorders

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bickel, W.K., Mellis, A.M., Snider, S.E. et al. Novel Therapeutics for Addiction: Behavioral Economic and Neuroeconomic Approaches. Curr Treat Options Psych 3, 277–292 (2016). https://doi.org/10.1007/s40501-016-0088-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40501-016-0088-3

Keywords

Navigation